期刊文献+

肝豆状核变性患者血凝指标与血小板检测的临床意义 被引量:5

Detection and Significance of Blood Coagulation Parameter and Platelet Count Measurement in Patients with Hepato-Lenticular Degeneration
下载PDF
导出
摘要 目的研究肝豆状核变性(HLD)患者的凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(Fib)和血小板(PLT)的变化及意义。方法对128例HLD患者和40例正常对照组用血凝仪检测PT、APTT、TT、Fib;血球仪检测PLT;全自动生化分析仪检测丙氨酸氨基转移酶(ALT)和胆碱酯酶(CHE)。结果 HLD组与正常对照组比较,PT(s)20.91±8.18、APTT(s)49.21±15.85、TT(s)17.98±3.18均明显延长,ALT(U)73.59±72.38明显增高,但Fib(g/L)1.68±0.68、PLT(×109/L)58.71±33.23和CHE(U)4 934.61±2 161.81明显降低,两者比较差异有统计学意义(P<0.01)。结论 HLD患者的PLT和血凝指标均有异常,可从多方面评价HLD患者凝血功能。 Objective To explore the changes and significance of prothrombin time(PT),activated partial thromboplastin time(APTT),fibrinogen(Fib),thrombin time(TT) and platelet count(PLT) in patients with hepato-lenticular degeneration(HLD).Methods To detect and analyze the indexes of APTT,PT,Fib and TT by blood coagulation analyzer,PLT by Auto Counter,ALT and CHE by HITACHI 7020 automatic analyzer in the experimental group of patients with HLD(n=128) and the control group of healthy people(n=40).Results In patients with HLD,PT(20.91±8.18)s,APTT(49.21±15.85)s,TT(17.98±3.18)s and ALT(73.59±72.38)U significantly increased,but Fib(1.68±0.68)g/L,PLT(58.71±33.23)×109/L and CHE(4 934.61±2 161.81) U obviously descended,those patients indices showed the significant difference compared with normal control subjects(P<0.01).Conclusion The changes of PT,APTT,TT,Fib and PLT in patients with HLD are determined,these indices can be used to evaluate the function of blood coagulation.
出处 《临床输血与检验》 CAS 2011年第3期231-233,共3页 Journal of Clinical Transfusion and Laboratory Medicine
关键词 肝豆状核变性 凝血酶原时间 纤维蛋白原 凝血酶时间 血小板 Hepato-Lenticular degeneration Prothrombin time Fibrinogen Thrombin time Platelet count
  • 相关文献

参考文献5

二级参考文献25

  • 1王兴族,李传付,王宁新,王金萍,宋执云,杨任民,鲍远程.38例肝豆状核变性的肝肾声像图研究[J].中华超声影像学杂志,1993,2(2):58-61. 被引量:25
  • 2邓岩,刘小平.血清胆碱脂酶活力测定对慢性肝炎诊治的临床意义[J].重庆医学,1997,26(1):16-17. 被引量:23
  • 3Cancado EL, Rocha MS, Barbosa ER, et al. Abdominal ultrasonography in hepatolenticular degeneration. A study of 33 patients [ J ]. Arq Neuropsiquiatr, 1987,45:131-136.
  • 4Smolka V, Frysak Z, Kozak L, et al. The hepatic form of Wilson' s disease in young patients[J]. Vnitr-Lek ,2000,46:24-29.
  • 5Lecca S, Pilloni L, Ambu R, et al. Multiple histochemical methods in the diagnosis of Wilson' s disease ( Presentation of 74 cases and review of the literature) [J]. Pathological, 1998,90:771-775.
  • 6Vogel W, Kathrein H, Dietze, O, et al. SOnography of the liver in wilson' s disease[J]. Ultraschall Med, 1988,9:270-273.
  • 7Goswami RP, Banerjee D, Shah DJ. Cholelithiasis in child-an unusual presentation of Wilson' s disease[J]. Assoc Physicians India, 2001,49: 1118-1119.
  • 8Vukovich T, Teufelsbauer H, Fritzer M, et al. Hemostasis activation in patients with liver cirrhosis. Thromb Res, 1995,77: 271-278.
  • 9Violi F, Leo R, Vezza E, et al. Bleeding time in patients with cirrhosis:relation with degree of liver failure and clotting abnormalities. C A L C Group. Coagulation Abnormalities in Cirrhosis Study Group. J Hepatol, 1994, 20: 531-536.
  • 10Sallah S, Bobzien W Bleeding problems in patients with liver disease:ways to manage the many hepatic effects on coagulation. Postgrad Med,1999,106: 187-190,193-195.

共引文献167

同被引文献54

引证文献5

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部